Search Result "IDH1"
Withaferin A Inhibits Liver Cancer Tumorigenesis by SuppressingAerobic Glycolysis through the p53/IDH1/HIF-1α Signaling Axis
Journal: Current Cancer Drug Targets
Volume: 24 Issue: 5 Year: 2024 Page: 534-545
Author(s):
Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
Journal: Medicinal Chemistry
Volume: 14 Issue: 7 Year: 2018 Page: 715-724
Author(s): Fangrui Wu,Gang Cheng,Yuan Yao,Mari Kogiso,Hong Jiang,Xiao-Nan Li,Yongcheng Song
Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer
Journal: Current Topics in Medicinal Chemistry
Volume: 18 Issue: 6 Year: 2018 Page: 505-524
Author(s): Horrick Sharma
Research Highlights BAY 1436032: A Novel Pan-mutant IDH1 Inhibitor Extends Survival of Mice with Experimental Brain Tumors
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 6 Year: 2017 Page: 636-637
Author(s): S. Gokul,G. K. Rajanikant
Targeting IDH Mutations in AML: Wielding the Double-edged Sword of Differentiation
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 7 Year: 2020 Page: 490-500
Author(s): Justin S. Becker,Amir T. Fathi
Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities?
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 15 Year: 2012 Page: 1683-1692
Author(s): Laetitia Padovani,Carole Colin,Carla Fernandez,Andre Maues de Paula,Sandy Mercurio,Didier Scavarda,Frederic Frassineti,Jose Adelaide,Anderson Loundou,Dominique Intagliata,Corinne Bouvier,Gabriel Lena,Daniel Birnbaum,Nadine Girard,Dominique Figarella-Branger
Cholangiocarcinoma Therapeutics: An Update
Journal: Current Cancer Drug Targets
Volume: 21 Issue: 6 Year: 2021 Page: 457-475
Author(s): Mai Ly Thi Nguyen,Nguyen Linh Toan,Maria Bozko,Khac Cuong Bui,Przemyslaw Bozko
Is Induction of Hypomethylation with Ivosidenib and 5-Azacitidine Curative Regimenagainst IDH1-Mutated Acute Myeloid Leukemia?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 8 Year: 2023 Page: 864-866
Author(s):
A Promising Breakthrough: The Potential of VORASIDENIB in the Treatmentof Low-grade Glioma
Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-5
Author(s):
Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic Management
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 42 Year: 2017 Page: 6464-6487
Author(s): Charles Vecht,Louis Royer-Perron,Caroline Houillier,Gilles Huberfeld